MAP2K7 and medulloblastoma: When we started to explore CREB activation as potential medulloblastoma treatment, alongside Bmps that are believed to activate CREB via MEK/ERK signaling, we included Forskolin (FSK), a potent activator of the cAMP/PKA pathway also targeting CREB43,44.